Alert detail
LCD L39720: MolDX: Molecular Testing for Risk Stratification of Thyroid Nodules — WPS
Policy ID: LCD-L39720Specialty: EndocrinologyAdded: 6/5/2026Effective: 2026-05-28lcd
What changed
Covers molecular testing for thyroid nodule risk stratification.
Who’s affected: Endocrinology billing teams · Effective: 2026-05-28
Primary source: View the official CMS/MAC document ↗
Get the action steps and full analysis
Subscribers get the recommended action (“what to do”), the full AI analysis, the LCD revision comparison, and related alerts across your specialty and jurisdiction.
Not ready to subscribe?
Get the free weekly reimbursement brief for Endocrinology— the week’s changes and deadlines, delivered to your inbox. No account required.